Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youngmin Han

Showing results (181-190 of 190) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 190 results.
Journal of Hepato-Biliary-Pancreatic Sciences|May 15, 2021
Multi-biomarker panel prediction model for diagnosis of pancreatic cancerDoo-Ho Lee, Woongchang Yoon, Areum Lee, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|December 19, 2018
Optimal surgical treatment in patients with T1b gallbladder cancer: An international multicenter studyHyeong Seok Kim, Jae Woo Park, Hongbeom Kim, et al.
The British Journal of Surgery|July 13, 2023
Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trialsDeesje Doppenberg, Jacob L van Dam, Youngmin Han, et al.
Gastroenterology|July 5, 2023
Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for DiscontinuationGiovanni Marchegiani, Tommaso Pollini, Anna Burelli, et al.
Nature Communications|August 26, 2020
Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidateAkhilesh Pandey, Eric W Stawiski, Steffen Durinck, et al.
Nature Cancer|May 19, 2023
Author Correction: Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypesDo Young Hyeon, Dowoon Nam, Youngmin Han, et al.
Nature Cancer|December 22, 2022
Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypesDo Young Hyeon, Dowoon Nam, Youngmin Han, et al.
BMC Cancer|February 24, 2026
Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, multicenter, prospective, randomized controlled trialHye-Sol Jung, Julian Choi, Se Jun Park, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|April 3, 2021
Development, validation, and comparison of a nomogram based on radiologic findings for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: An international multicenter studyHyeong Seok Kim, Wookyeong Song, Wonho Choo, et al.
Scientific Reports|November 19, 2020
Risk prediction for malignant intraductal papillary mucinous neoplasm of the pancreas: logistic regression versus machine learningJae Seung Kang, Chanhee Lee, Wookyeong Song, et al.
Pageof 19

Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
Journal of Hepato-Biliary-Pancreatic Sciences|May 15, 2021
Multi-biomarker panel prediction model for diagnosis of pancreatic cancerDoo-Ho Lee, Woongchang Yoon, Areum Lee, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|December 19, 2018
Optimal surgical treatment in patients with T1b gallbladder cancer: An international multicenter studyHyeong Seok Kim, Jae Woo Park, Hongbeom Kim, et al.
The British Journal of Surgery|July 13, 2023
Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trialsDeesje Doppenberg, Jacob L van Dam, Youngmin Han, et al.
Gastroenterology|July 5, 2023
Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for DiscontinuationGiovanni Marchegiani, Tommaso Pollini, Anna Burelli, et al.
Nature Communications|August 26, 2020
Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidateAkhilesh Pandey, Eric W Stawiski, Steffen Durinck, et al.
Nature Cancer|May 19, 2023
Author Correction: Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypesDo Young Hyeon, Dowoon Nam, Youngmin Han, et al.
Nature Cancer|December 22, 2022
Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypesDo Young Hyeon, Dowoon Nam, Youngmin Han, et al.
BMC Cancer|February 24, 2026
Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, multicenter, prospective, randomized controlled trialHye-Sol Jung, Julian Choi, Se Jun Park, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|April 3, 2021
Development, validation, and comparison of a nomogram based on radiologic findings for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: An international multicenter studyHyeong Seok Kim, Wookyeong Song, Wonho Choo, et al.
Scientific Reports|November 19, 2020
Risk prediction for malignant intraductal papillary mucinous neoplasm of the pancreas: logistic regression versus machine learningJae Seung Kang, Chanhee Lee, Wookyeong Song, et al.
Pageof 19